Drug
Dm199
Dm199: highest development phase Phase 2, developed by DiaMedica Therapeutics Inc. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- DiaMedica Therapeutics Inc
Trials
| Drug | Phase | Indication |
|---|---|---|
| DM199 NCT04123613 | Phase 2 | Kidney Diseases |
Latest
No recent events.
Follow Dm199 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.